GRDN
Guardian Pharmacy·NYSE
--
--(--)
--
--(--)
5.24 / 10
Netural
Analyst sentiment is overwhelmingly bullish with a 100% Buy rating from Stephens & Co., yet fund-flow trends are mixed: Small and Large flows lean positive, while overall and Medium patterns show mild outflows. The fund-flow score of 7.71 indicates healthy capital interest, but not decisively bullish. Overall, the stock sits in a neutral-to-positive gray area, ideal for staggered positioning.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-14
InstitutionStephens & Co.
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for GRDN?
- GRDN holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.24/10 (Netural).
